|
Volumn 59, Issue 4, 2000, Pages 296-301
|
Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy
|
Author keywords
Chemotherapy; Metastasis; Pancreatic cancer; Prognosis; Prognostic factor
|
Indexed keywords
C REACTIVE PROTEIN;
CA 19-9 ANTIGEN;
CISPLATIN;
DOCETAXEL;
EPIRUBICIN;
FLUOROURACIL;
GEMCITABINE;
IRINOTECAN;
METHOTREXATE;
TEGAFUR;
ADULT;
AGED;
ANTIGEN EXPRESSION;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
PANCREAS ADENOCARCINOMA;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN BLOOD LEVEL;
|
EID: 0033673070
PISSN: 00302414
EISSN: None
Source Type: Journal
DOI: 10.1159/000012186 Document Type: Article |
Times cited : (93)
|
References (26)
|